Trinity Biotech ADR buy StockNews.com
Start price
15.10.23
/
50%
€0.49
Target price
15.10.24
-
Performance (%)
-13.82%
Price
22.02.24
€0.41
Summary
This prediction is currently active. The price of Trinity Biotech ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.82%. This prediction currently runs until 15.10.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | 1.662% | 4.835% |
iShares Nasdaq 100 | 0.667% | 0.000% |
iShares Nikkei 225® | -2.139% | -4.786% |
iShares S&P 500 | 0.564% | 0.775% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat